Horizon Europe – MSCA Doctoral Networks
Partner organizations
Universität Bern – Swiss Cardiovascular Center, Inselspital (Bern, Switzerland)
Universität Bern participates in LipidBRIGHT as an associated partner supported by a Swiss government funding guarantee. Research activities are embedded in the Division of Angiology at the Swiss Cardiovascular Center, Inselspital. The group contributes expertise in vascular inflammation, lipid-driven vascular pathology, and translational cardiovascular research, and is involved in doctoral training, secondments, and supervision within the network.
​
Scientific lead:
Prof. Dr. Yvonne Döring
Leadership Sculptor
GmbH (Germany)
Leadership Sculptor GmbH is a company specialised in leadership development and transferable skills training for researchers and R&D professionals. Within LipidBRIGHT, Leadership Sculptor contributes training in leadership, innovation, and personal development, supporting doctoral candidates in acquiring skills essential for careers in academia, industry, and beyond.
​
Scientific lead:
PD Dr. Conor John Fitzsimons
European
Kidney Health Alliance
(Belgium)
The European Kidney Health Alliance (EKHA) is a non-profit organisation representing key stakeholders in kidney health at the European level. EKHA contributes expertise in dissemination, outreach, and stakeholder engagement, facilitating interactions with patient organisations, healthcare professionals, and policymakers, and supporting the societal impact and sustainability of LipidBRIGHT.
​
Scientific lead:
Prof. Dr. Raymond Vanholder
Nancyclotep
(Nancy, France)
Nancyclotep is a clinical research and imaging platform specialised in translational cardiovascular research. Within LipidBRIGHT, Nancyclotep contributes to doctoral training and secondments, providing expertise in clinical translation and advanced imaging approaches relevant to lipid-driven cardiovascular pathology.
​
Scientific lead:
Dr. Fatiha Maskali
Aspect Analytics
(Belgium)
Aspect Analytics is a data-science company specialising in bioinformatics, artificial intelligence, and advanced analytics for biomedical research. Within LipidBRIGHT, Aspect Analytics contributes expertise in AI-supported multi-omics analysis, biomarker discovery, and disease modelling, and is involved in secondments and doctoral training.
​
Scientific lead:
Dr. Nico Verbeeck
CordenPharma International GmbH (Switzerland / Italy)
CordenPharma International GmbH is a global pharmaceutical services company with expertise in drug substance and drug product development. Within LipidBRIGHT, CordenPharma contributes expertise in lipid synthesis, formulation, and lipid-based drug delivery technologies, supporting translational research and doctoral training through secondments.
​
Scientific lead:
Dr. Adriano Indolese
Boehringer Ingelheim
Pharma GmbH (Germany)
Boehringer Ingelheim Pharma GmbH is a global pharmaceutical company with strong research activities in cardio-metabolic diseases. Within LipidBRIGHT, Boehringer Ingelheim contributes to doctoral training through workshops and expertise in clinical development and translational research.
​
Scientific lead:
Dr. Remko Bakker
Karolinska Institutet
(Stockholm, Sweden)
Karolinska Institutet is one of Europe’s leading medical universities. Within LipidBRIGHT, research is embedded in the Laboratory of Immunobiology, Department of Medicine. The group contributes expertise in lipid mediator biology, inflammation, and advanced lipidomics, and is involved in doctoral training and secondments.
​
Scientific lead:
Dr. Craig Wheelock
University of Skövde
(Skövde, Sweden)
The University of Skövde contributes expertise in bioinformatics and data science. Within LipidBRIGHT, the Department of Biology and Bioinformatics supports doctoral training and secondments in omics data analysis and computational biology.
​
Scientific lead:
Prof. Dr. Jane Synnergren
Netherlands Oils and Fats Industry (The Netherlands)
The Netherlands Oils and Fats Industry (MVO) is an industry association representing stakeholders in the oils and fats sector. Within LipidBRIGHT, MVO contributes to dissemination, outreach, and stakeholder engagement, supporting knowledge transfer between research, industry, and the general public.
​
Scientific lead:
Nicole Vervaet
Fresenius Medical Care Deutschland GmbH
(Germany)
Fresenius Medical Care Deutschland GmbH is a global healthcare company specialising in dialysis products and services. Within LipidBRIGHT, Fresenius Medical Care contributes to doctoral training through workshops and provides expertise relevant to clinical translation in chronic kidney disease.
​
Scientific lead:
Dr. Dorothea Piecha
Danone Global Research &
Innovation Center BV (The Netherlands)
Danone Global Research & Innovation Center BV is the R&D arm of Danone, focusing on nutrition and health. Within LipidBRIGHT, Danone contributes expertise in nutritional science and lipid-based interventions, supporting doctoral training through workshops related to lipids and health.
​
Scientific lead:
Prof. Dr. Johan Garssen
German Research Center for Artificial Intelligence
(Germany)
The German Research Center for Artificial Intelligence (DFKI) is one of the world’s leading research centres in artificial intelligence. Within LipidBRIGHT, DFKI contributes expertise in data science and AI-based omics analysis and is involved in doctoral training and secondments.
​
Scientific lead:
Prof. Dr. Sebastian Vollmer
Universitätsklinikum
Aachen
(Aachen, Germany)
Universitätsklinikum Aachen is a large university hospital with strong expertise in cardiovascular medicine. Within LipidBRIGHT, the Department of Cardiology contributes to doctoral training and secondments, providing clinical expertise relevant to lipid-driven cardiovascular disease.
​
Scientific lead:
Prof. Dr. Dirk Müller-Wieland
EUTox work group e.V.
(Europe)
EUTox is a European working group focusing on uremic toxins and their role in chronic kidney disease and associated cardiovascular pathology. Within LipidBRIGHT, EUTox contributes to training, dissemination, outreach, and stakeholder engagement, supporting the network’s long-term sustainability and translational impact.
​
Scientific lead:
Prof. Dr. Griet Glorieux